Show simple item record

MDAH- 2774 over kanser kök hücrelerinde kemoterapi sonrası apoptotik etkilerin incelenmesi

dc.contributor.authorB Demiray, S
dc.contributor.authorAyla, Ş
dc.contributor.authorOltulu, F
dc.contributor.authorÇavuşoğlu, T
dc.contributor.authorAkarca, Ö
dc.contributor.authorY Dilsiz, Ö
dc.contributor.authorErgüven, M.
dc.contributor.authorÖktem, G
dc.date.accessioned2021-12-21T08:31:53Z
dc.date.available2021-12-21T08:31:53Z
dc.date.issued2011
dc.identifier.issn1016-9113
dc.identifier.issn2147-6500
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TVRNME1EVTFOUT09/mdah-2774-over-kanser-kok-hucrelerinde-kemoterapi-sonrasi-apoptotik-etkilerin-incelenmesi
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/889
dc.description.abstractAmaç: Mortalitesi en yüksek jinekolojik kanser olan over kanserinin tedavisindeki asıl problem nüks ve kemoterapi direncidir. Kanser dokusunda, patogenezisden sorumlu tutulan, artmıs büyüme potansiyeline sahip, uzun ömürlü hücre popülasyonu kanser kök h
dc.description.abstractAim: A major problem in the treatment of ovarian cancer, which has the highest mortality rates among gyneacological malignancies, is recurrence and chemoresistance. In the cancer tissue, this population of long-lived cells with extraordinary expansion p
dc.language.isoTurkish
dc.titleMDAH- 2774 over kanser kök hücrelerinde kemoterapi sonrası apoptotik etkilerin incelenmesi
dc.title.alternativeApoptotic effects of chemotheraphy in the MDAH- 2774 ovarian cancer stem cell
dc.relation.journalEge Tıp Dergisi
dc.identifier.issue2
dc.identifier.startpage103
dc.identifier.endpage109
dc.identifier.volume50
dc.relation.issue2
dc.relation.volume50


Files in this item

Thumbnail
Name:
MDAH- 2774 over kanser kök ...
Size:
632.1Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record